Preprint · CC-BY
via bioRxiv
Classifying Mild Cognitive Impairment from Normal Cognition: fMRI Complexity Matches Tau PET Performance
biorxiv · 2025
Abstract
BackgroundTau protein accumulation is closely linked to synaptic and neuronal loss in Alzheimers disease (AD), resulting in progressive cognitive decline. Although tau-PET imaging is a direct biomarker of tau pathology, it is costly, carries radiation risks, and is not widely accessible. Resting-state functional MRI (rs-fMRI) complexity--an entropy-based measure of BOLD signal variation--has been proposed as a non-invasive surrogate biomarker of early neuronal dysfunction associated with tau pathology.
ObjectivesTo determine whether fMRI-based brain complexity (sample entropy and multiscale entropy) can match or exceed tau-PET in classifying cognitively normal (CN) versus cognitively impaired (MCI/AD) individuals. And to investigate and compare the most influential network regions-of-interest (ROIs) for classification between fMRI complexity and tau-PET, thereby identifying key neuroanatomical correlates of AD-related changes.
DesignA cross-sectional study employing 3D convolutional neural network (CNN) classification with five-fold cross-validation and leave-one-network-out analysis.
SettingData from the Alzheimers Disease Neuroimaging Initiative (ADNI) database.
ParticipantsOne hundred forty-seven older adults (age 72.5 {+/-} 7.5 years), including 95 CN, 45 MCI, and 7 AD.
MeasurementsWe created whole-brain complexity maps from rs-fMRI and standardized uptake value ratio (SUVR) maps from tau-PET. Each modality was separately fed into CNN classifiers. Region-based analyses (leave-one-network-out) were performed to identify critical ROIs for classification.
ResultsfMRI complexity showed classification accuracy comparable to tau-PET yet surpassed it in F1-score (0.64 vs. 0.61) and area under the curve (AUC; 0.73 vs. 0.67). Salience and dorsal attention networks contributed most to fMRI-based classification, and a dorsal attention network contributed most to tau-PET-based classification.
ConclusionsfMRI complexity performs similarly to tau-PET in detecting cognitive impairment related to AD and identifies partially distinct critical ROIs, suggesting an alternative, radiation- free imaging biomarker for earlier detection and broader clinical application.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- bioRxiv
- DOI
- 10.1101/2025.01.16.633407
- Canonical
- link ↗
- Fetched
- 2026-10-06 MST
Cite this
APA
K., J., G., P., & H., K. (2025). Classifying Mild Cognitive Impairment from Normal Cognition: fMRI Complexity Matches Tau PET Performance. <em>biorxiv</em>. https://doi.org/10.1101/2025.01.16.633407
Vancouver
K. J, G. P, H. K. Classifying Mild Cognitive Impairment from Normal Cognition: fMRI Complexity Matches Tau PET Performance. biorxiv. 2025. doi:10.1101/2025.01.16.633407.
BibTeX
@unpublished{jann2025Classi,
title = {Classifying Mild Cognitive Impairment from Normal Cognition: fMRI Complexity Matches Tau PET Performance},
author = {Jann, K. and Park, G. and Kim, H.},
journal = {biorxiv},
year = {2025},
doi = {10.1101/2025.01.16.633407},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Columbia University 2023
Open access · US-GOV
Evaluation of Brain Changes in Cerebral Palsy Patients
Seoul National University Hospital 2014
Open access · US-GOV
Korean Brain Aging Study for Early Diagnosis and Prediction of Alzheimer's Disease
University of Florida 2006
Open access · US-GOV
Biological Effects of Weight Loss Plus Exercise in Obese Older African-American Women: An Investigation of Aging-related Changes in Black and White Women
Communications Medicine 2025
Open access · CC-BY
Plasma-based brain age as a potential biomarker for cognitive health and risk of brain-related disorders
Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring 2020
Open access · CC-BY
Plasma amyloid, tau, and neurodegeneration biomarker profiles predict Alzheimer's disease pathology and clinical progression in older adults without dementia
Massachusetts General Hospital 2025
Open access · US-GOV